#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myxoid liposarcoma Carcinoid syndrome Necrotising enterocolitis neonatal Insulinoma Primary immunodeficiency syndrome Henoch-Schonlein purpura nephritis Acute graft versus host disease in skin Synovial sarcoma metastatic Primary amyloidosis Transitional cell carcinoma Cortical dysplasia Familial haemophagocytic lymphohistiocytosis Small cell lung cancer Infantile spasms Gastrointestinal disorder More trials…

    Learn about Rare Diseases

    Hereditary ataxia Pemphigoid – Trials in Disease Von Willebrand’s disease Mucous membrane pemphigoid – Basic Information Antisynthetase syndrome – Treatment Wiskott-Aldrich syndrome Erdheim-Chester disease – Treatment Chronic granulomatous disease – Life with Disease Hairy cell leukaemia recurrent – Trials in Disease Osteosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Azithromycin Dihydrate Glatiramer Acetate MAGNESIUM ACETATE TETRAHYDRATE Alnuctamab Fexofenadine Darunavir Oxycodone Hydrochloride Hydroxychloroquine Sulfate Enlicitide Chloride Ciclesonide Belzutifan Enoxaparin Sodium Zinc Acexamate Lithium Carbonate Phenylephrine Resamirigene Bilparvovec Oteracil Glpg3667 Fumarate Levodropropizine Bromocriptine More therapies…

    Learn about Your Condition

    Haemorrhage intracranial Clinically isolated syndrome Post procedural infection Breast angiosarcoma metastatic Lymphatic malformation Graft versus host disease Neurogenic bladder Oropharyngeal cancer recurrent Growth hormone deficiency Pain Adenovirus infection Lymphocytic leukaemia Febrile neutropenia Spinal muscular atrophy Cardiomyopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on Rifamycin SV for Patients with Mild to Moderate Left-Sided Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Drugs:
    • Rifamycin Sodium
    Bulgaria Estonia Hungary Latvia Lithuania Poland +1

  • Study on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Human Serum Albumin
    Austria Belgium Bulgaria Croatia France Germany +5

  • Study of ALX148 with Trastuzumab, Ramucirumab, and Paclitaxel for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Ramucirumab
    • Paclitaxel
    • Trastuzumab
    Belgium Czechia France Italy Spain

  • Study on GSK4532990 for Adults with Nonalcoholic Steatohepatitis (NASH)

    Not recruiting

    2 1
    Investigated Diseases:
    • Metabolic dysfunction-associated liver disease
    Investigated Drugs:
    • Gsk4532990A
    Belgium France Greece Italy Spain

  • Study on Durvalumab and Chemotherapy for Patients with Advanced Biliary Tract Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Biliary tract disorder
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Durvalumab
    France Germany Italy Spain

  • Study on Baricitinib for Treating Large Inflammatory Liver Adenomas in Women and Non-Resectable Cases in Men

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatic adenoma
    Investigated Drugs:
    • Baricitinib
    France
Previous Page
1 … 73 74 75 76 77 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!